The role of CFTR mutations in asthma
- PMID: 22332134
- PMCID: PMC3299039
- DOI: 10.1155/2012/267251
The role of CFTR mutations in asthma
Comment on
-
Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis.Can Respir J. 2012 Jan-Feb;19(1):46-8. doi: 10.1155/2012/546702. Can Respir J. 2012. PMID: 22332135 Free PMC article.
References
-
- Warner JO, Norman AP, Soothill JF. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976;1:990–1. - PubMed
-
- Gyurkovits K, Markus V, Bittera I. Cystic-fibrosis heterozygosity in childhood bronchial asthma. Lancet. 1977;1:203. - PubMed
-
- Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis. 1984;129:911–4. - PubMed
-
- Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med. 1995;1:703–5. - PubMed
-
- Mennie M, Gilfillan A, Brock DJ, Liston WA. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med. 1995;1:978–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
